Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2006-12-13
pubmed:abstractText
Kaposi's sarcoma (KS) is an AIDS-defining condition in individuals with human immunodeficiency virus type 1 infection. We investigated the phenotype and function of the NKG2C+ NK cell population in individuals with AIDS and Kaposi's sarcoma. The staging of AIDS KS patients according to the AIDS Clinical Trial Group criteria revealed that patients with the S1 disease stage have a significantly higher proportion of NKG2C+ cells than those with the S0 disease stage. NKG2C+ cells from S1-stage patients are highly enriched for the expression of KIR3DL1, are depleted of NKp46, and respond poorly to major histocompatibility complex class I-positive target cells. These data demonstrate a link between NK cell phenotype and function and disease prognosis in AIDS.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/17035308-11216935, http://linkedlifedata.com/resource/pubmed/commentcorrection/17035308-11596074, http://linkedlifedata.com/resource/pubmed/commentcorrection/17035308-12134147, http://linkedlifedata.com/resource/pubmed/commentcorrection/17035308-12355422, http://linkedlifedata.com/resource/pubmed/commentcorrection/17035308-12938217, http://linkedlifedata.com/resource/pubmed/commentcorrection/17035308-12960839, http://linkedlifedata.com/resource/pubmed/commentcorrection/17035308-14632753, http://linkedlifedata.com/resource/pubmed/commentcorrection/17035308-14645713, http://linkedlifedata.com/resource/pubmed/commentcorrection/17035308-15219995, http://linkedlifedata.com/resource/pubmed/commentcorrection/17035308-15220032, http://linkedlifedata.com/resource/pubmed/commentcorrection/17035308-15304389, http://linkedlifedata.com/resource/pubmed/commentcorrection/17035308-15604012, http://linkedlifedata.com/resource/pubmed/commentcorrection/17035308-15699323, http://linkedlifedata.com/resource/pubmed/commentcorrection/17035308-15771571, http://linkedlifedata.com/resource/pubmed/commentcorrection/17035308-15784466, http://linkedlifedata.com/resource/pubmed/commentcorrection/17035308-15940674, http://linkedlifedata.com/resource/pubmed/commentcorrection/17035308-16160163, http://linkedlifedata.com/resource/pubmed/commentcorrection/17035308-16227783, http://linkedlifedata.com/resource/pubmed/commentcorrection/17035308-16239902, http://linkedlifedata.com/resource/pubmed/commentcorrection/17035308-16384928, http://linkedlifedata.com/resource/pubmed/commentcorrection/17035308-16474394, http://linkedlifedata.com/resource/pubmed/commentcorrection/17035308-16741880, http://linkedlifedata.com/resource/pubmed/commentcorrection/17035308-9294471
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0022-538X
pubmed:author
pubmed:issnType
Print
pubmed:volume
81
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
430-3
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2007
pubmed:articleTitle
NKG2C+ NK cells are enriched in AIDS patients with advanced-stage Kaposi's sarcoma.
pubmed:affiliation
Department of Immunology, Imperial College London, United Kingdom. m.goodier@imperial.ac.uk.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't